Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barre syndrome
R. Gruenewald, A. H. Ropper, H. Lior, J. Chan, R. Lee and V. S. Molinaro
Enteric Bacteriology Laboratory, St Elizabeth's Hospital, Boston, MA 02135.
We performed serologic testing for Campylobacter jejuni in 17 consecutive
patients with acute Guillain-Barre syndrome from the Boston, Mass area to
compare the frequency of this preceding infection with the high rates
reported from other areas of the world. The rate of seropositivity, 18%,
was considerable, but it was lower than that reported in Australia.
Moreover, all of our patients with definite serologic evidence of infection
had severe enteritis before Guillain-Barre syndrome, usually with the
organism cultured from stool samples. Campylobacter enteritis is an
important antecedent illness for Guillain-Barre syndrome but did not
precipitate the disease without enteritis.